“We were told to trust the science, but it wasn’t science that was being offered to us.“
The study begins with the obligatory homage to mRNA technology, damning it with faint praise as ’a significant technological advance’, which is a misrepresentation still necessary to ensure the paper’s acceptance for publication (yes, journals are still clinging on to the fantasy). It then plunges into the detailed story of cancer vulnerability. It examines the impact of covid vaccinations on the survival of 272 PC patients admitted to hospital between January 2018 and November 2023.
Pancreatic cancer is aggressive with a low survival rate (about 10-12 per cent after five years). It is often detected at a late stage when it is already invading nearby structures, eventually metastasising to other parts of the body. The Japanese study found that repeated covid booster vaccinations are associated with poorer overall survival in patients with PC: ‘Patient outcomes had improved each year by 2020; however, it began to deteriorate in 2021 and outcomes in 2022-2023 were significantly worse than those in 2018-2021.’
The authors investigated a possible mechanism and concluded: ‘Notably, our analysis reveals that high levels of IgG4 [an immune suppressant we have discussed in many previous reports including our Open Letter to Medical Professionals and Life Scientists induced by vaccination, correlate with a detrimental prognosis in these patients. These insights provide essential information regarding the interplay between vaccination and cancer progression, which has significant implications for patient management strategies. Our study highlights the necessity for ongoing research into the long-term effects of mRNA vaccinations on cancer prognosis, which remains a pressing concern in the evolving landscape of public health and cancer treatment.’
The complex statistical analysis involved detailed consideration and matching into groups for age, sex, comorbidities, treatment history, vaccination history, etc. Overall those vaccinated twice had a longer survival than those vaccinated three times (p=0.006). Microbiological testing found a reduced immune response in the three-times-vaxxed group compared with those vaxxed twice. The study did not examine outcomes for other cancer types. I leave this omission for your reflection.